Published in JOP on May 05, 2010
In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging. Proc Natl Acad Sci U S A (2011) 1.42
Early diagnosis of pancreatic cancer: challenges and new developments. Biomark Med (2012) 1.23
Screening for pancreatic cancer: why, how, and who? Ann Surg (2013) 1.19
Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis. J Proteome Res (2014) 1.04
Molecular biology of pancreatic cancer. World J Gastroenterol (2011) 1.02
Genetic predisposition to pancreatic cancer. World J Gastroenterol (2014) 0.94
Pancreatic Cancer Database: an integrative resource for pancreatic cancer. Cancer Biol Ther (2014) 0.94
PCCR: Pancreatic Cancer Collaborative Registry. Cancer Inform (2011) 0.92
Monitoring pancreatic carcinogenesis by the molecular imaging of cathepsin E in vivo using confocal laser endomicroscopy. PLoS One (2014) 0.87
Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls. BMC Cancer (2013) 0.83
High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening. J Surg Res (2014) 0.83
Current status and progress of pancreatic cancer in China. World J Gastroenterol (2015) 0.83
Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric labeling quantitative method. J Proteome Res (2014) 0.78
Association between E-cadherin (CDH1) polymorphisms and pancreatic cancer risk in Han Chinese population. Int J Clin Exp Pathol (2015) 0.77
Significance of microRNA-based biomarkers for pancreatic cancer. Ann Transl Med (2015) 0.77
Association between alcohol consumption and pancreatic cancer risk: a case-control study. PLoS One (2015) 0.77
Familial pancreatic cancer. Cancers (Basel) (2010) 0.75
Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer. Pancreas (2016) 0.75
The use of multidimensional data to identify the molecular biomarker for pancreatic ductal adenocarcinoma. Biomed Res Int (2013) 0.75
Quality indicators for colonoscopy. Gastrointest Endosc (2014) 4.17
Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol (2012) 3.59
ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc (2006) 3.12
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. J Clin Oncol (2014) 3.07
ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc (2006) 2.63
Establishing a true assessment of endoscopic competence in ERCP during training and beyond: a single-operator learning curve for deep biliary cannulation in patients with native papillary anatomy. Gastrointest Endosc (2007) 2.60
Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw (2010) 2.45
ASGE guideline: The role of endoscopy in acute non-variceal upper-GI hemorrhage. Gastrointest Endosc (2004) 2.33
Celiac plexus neurolysis for pain relief in pancreatic cancer. J Support Oncol (2009) 2.32
ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc (2005) 2.11
Esophageal stenting for the palliation of malignant dysphagia. J Support Oncol (2008) 2.08
Endoscopic therapy for malignant bowel obstruction. J Support Oncol (2007) 2.07
Quality indicators for colonoscopy. Am J Gastroenterol (2014) 2.06
ASGE Guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005. Gastrointest Endosc (2005) 1.99
A retrospective study of nurse-assisted propofol sedation in patients with amyotrophic lateral sclerosis undergoing percutaneous endoscopic gastrostomy. Nutr Clin Pract (2012) 1.98
Endoscopic mucosal resection and endoscopic submucosal dissection. Gastrointest Endosc (2008) 1.95
Overtube use in gastrointestinal endoscopy. Gastrointest Endosc (2009) 1.94
Chromoendoscopy. Gastrointest Endosc (2007) 1.74
ASGE guideline: The role of endoscopy in the diagnosis and the management of cystic lesions and inflammatory fluid collections of the pancreas. Gastrointest Endosc (2005) 1.74
Esophageal dilation. Gastrointest Endosc (2006) 1.68
Narrow band imaging and multiband imaging. Gastrointest Endosc (2008) 1.65
Self-expanding metal stents (SEMS) for preoperative biliary decompression in patients with resectable and borderline-resectable pancreatic cancer: outcomes in 241 patients. Dig Dis Sci (2012) 1.55
EUS training and practice patterns among gastroenterologists completing training since 1993. Gastrointest Endosc (2005) 1.51
Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol (2005) 1.50
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. J Natl Compr Canc Netw (2014) 1.48
Rapid on-site evaluation reduces needle passes in endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesions: a risk-benefit analysis. Dig Dis Sci (2013) 1.46
Cholangiocarcinoma in a 17-year-old boy with primary sclerosing cholangitis and UroVysion™ fluorescent in situ hybridization. Diagn Cytopathol (2011) 1.40
Small-intestinal B-cell lymphoma manifesting as pneumobilia secondary to involvement of the major duodenal papilla. Gastrointest Endosc (2006) 1.39
Fast-food bolus nation. Gastrointest Endosc (2006) 1.39
ASGE Guideline: the role of endoscopy in the patient with lower-GI bleeding. Gastrointest Endosc (2005) 1.39
Clinical Outcomes, Efficacy, and Adverse Events in Patients Undergoing Esophageal Stent Placement for Benign Indications: A Large Multicenter Study. J Clin Gastroenterol (2016) 1.38
ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc (2006) 1.36
EUS vs MRCP for detection of choledocholithiasis. Gastrointest Endosc (2006) 1.35
Large colonic lipomas. Gastroenterol Hepatol (N Y) (2011) 1.33
A comparative needle study: EUS-FNA procedures using the HD ProCore(™) and EchoTip(®) 22-gauge needle types. Diagn Cytopathol (2013) 1.32
ASGE guideline: complications of EUS. Gastrointest Endosc (2005) 1.32
Stenting of the proximal colon in patients with malignant large bowel obstruction: techniques and outcomes. Gastrointest Endosc (2007) 1.31
Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad Dermatol (2009) 1.30
Can U.S. GI fellowship programs meet American Society for Gastrointestinal Endoscopy recommendations for training in EUS? A survey of U.S. GI fellowship program directors. Gastrointest Endosc (2006) 1.29
The role of endoscopy in ampullary and duodenal adenomas. Gastrointest Endosc (2006) 1.28
The role of endoscopy in patients with chronic pancreatitis. Gastrointest Endosc (2006) 1.26
Large colonic lipoma mimicking colon cancer and causing colonic intussusception. Dig Dis Sci (2008) 1.25
Principles of training in GI endoscopy. Gastrointest Endosc (2011) 1.25
ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures. Gastrointest Endosc (2005) 1.23
Role of EUS. Gastrointest Endosc (2007) 1.23
Needle size has only a limited effect on outcomes in EUS-guided fine needle aspiration: a systematic review and meta-analysis. Dig Dis Sci (2012) 1.23
CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families. Cancer Epidemiol Biomarkers Prev (2008) 1.22
Colonoscopy core curriculum. Gastrointest Endosc (2012) 1.20
Elemental diet induces histologic response in adult eosinophilic esophagitis. Am J Gastroenterol (2013) 1.20
Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol (2008) 1.20
Screening for pancreatic cancer: why, how, and who? Ann Surg (2013) 1.19
Hamartomatous polyposis syndromes. Best Pract Res Clin Gastroenterol (2009) 1.18
Quality indicators common to all GI endoscopic procedures. Gastrointest Endosc (2014) 1.17
Capsule endoscopy of the colon. Gastrointest Endosc (2008) 1.16
ASGE Guideline: Guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc (2005) 1.13
Placement of fully covered self-expandable metal stents in patients with locally advanced esophageal cancer before neoadjuvant therapy. Gastrointest Endosc (2012) 1.13
Rapid on-site evaluation increases endoscopic ultrasound-guided fine-needle aspiration adequacy for pancreatic lesions. Dig Dis Sci (2012) 1.12
Genetics of colorectal cancer. Oncology (Williston Park) (2006) 1.09
Osteoclastic and pleomorphic giant cell tumors of the pancreas diagnosed via EUS-guided FNA: unique clinical, endoscopic, and pathologic findings in a series of 5 patients. Gastrointest Endosc (2009) 1.08
EUS in pediatric patients. Gastrointest Endosc (2009) 1.07
Metastatic disease to the pancreas documented by endoscopic ultrasound guided fine-needle aspiration: a seven-year experience. Diagn Cytopathol (2010) 1.07
Endoscopic hemostatic devices. Gastrointest Endosc (2009) 1.05
Comorbidities, sphincterotomy, and balloon dilation predict post-ERCP adverse events in PSC patients: operator experience is protective. Dig Dis Sci (2011) 1.05
ASGE guideline: modifications in endoscopic practice for the elderly. Gastrointest Endosc (2006) 1.03
Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Am J Gastroenterol (2010) 1.03
Colonoscopy preparation. Gastrointest Endosc (2009) 1.01
Role of endoscopy in the management of GERD. Gastrointest Endosc (2007) 1.00
Multicenter comparison of the interobserver agreement of standard EUS scoring and Rosemont classification scoring for diagnosis of chronic pancreatitis. Gastrointest Endosc (2010) 1.00
Utility of the short double-balloon enteroscope to perform pancreaticobiliary interventions in patients with surgically altered anatomy in a US multicenter study. Dig Dis Sci (2012) 1.00
Informed consent for GI endoscopy. Gastrointest Endosc (2007) 0.99
Melanoma genetic counseling and test reporting improve screening adherence among unaffected carriers 2 years later. Cancer Epidemiol Biomarkers Prev (2013) 0.99
Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma. Pancreas (2013) 0.98
Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome. Psychooncology (2011) 0.98
Complications of temporary pancreatic stent insertion for pancreaticojejunal anastomosis during pancreaticoduodenectomy. Gastrointest Endosc (2004) 0.97
Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw (2006) 0.97
Biliary and pancreatic stone extraction devices. Gastrointest Endosc (2009) 0.96
Primary sclerosing cholangitis and distribution of inflammatory bowel disease. Clin Gastroenterol Hepatol (2012) 0.95
Endoscopic retrieval devices. Gastrointest Endosc (2009) 0.95
Motivation-based intervention to promote colonoscopy screening: an integration of a fear management model and motivational interviewing. J Health Psychol (2011) 0.94
Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome. Gynecol Oncol (2012) 0.94
Malignant biliary tract obstruction: evaluation and therapy. J Natl Compr Canc Netw (2010) 0.94
Patterns of photoprotection following CDKN2A/p16 genetic test reporting and counseling. J Am Acad Dermatol (2009) 0.94
High-resolution and high-magnification endoscopes. Gastrointest Endosc (2009) 0.94
Confocal laser endomicroscopy. Gastrointest Endosc (2009) 0.94
Endoscopic biliary sphincterotomy is not required for transpapillary SEMS placement for biliary obstruction. Dig Dis Sci (2010) 0.94
Effect of the time of day and queue position in the endoscopic schedule on the performance characteristics of endoscopic ultrasound-guided fine-needle aspiration for diagnosing pancreatic malignancies. Endosc Ultrasound (2016) 0.93
Endocytoscopy. Gastrointest Endosc (2009) 0.93
ASGE guideline: guidelines for credentialing and granting privileges for capsule endoscopy. Gastrointest Endosc (2005) 0.93
Interventional EUS. Gastrointest Endosc (2010) 0.92
Echoendoscopes. Gastrointest Endosc (2007) 0.92
Short-wire ERCP systems. Gastrointest Endosc (2007) 0.92
Enteral stents for malignant gastric outlet obstruction. Gastrointest Endosc Clin N Am (2011) 0.92
Quality indicators for EGD. Gastrointest Endosc (2014) 0.92
Quality indicators for ERCP. Gastrointest Endosc (2014) 0.92
Initial experience of assessing esophageal tissue injury and recovery using delayed-enhancement MRI after atrial fibrillation ablation. Circ Arrhythm Electrophysiol (2009) 0.92
Osteoclastic and pleomorphic giant cell tumors of the pancreas: A review of clinical, endoscopic, and pathologic features. World J Gastrointest Endosc (2010) 0.91
Post-ERCP pancreatitis: review of current preventive strategies. Curr Opin Gastroenterol (2012) 0.90
Quality indicators for EUS. Gastrointest Endosc (2014) 0.90
Parental preferences for CDKN2A/p16 testing of minors. Genet Med (2010) 0.89
ERCP cannulation and sphincterotomy devices. Gastrointest Endosc (2010) 0.89